DongBang Medical Co Ltd
KOSDAQ:240550
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
DongBang Medical Co Ltd
PP&E Gross
DongBang Medical Co Ltd
PP&E Gross Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DongBang Medical Co Ltd
KOSDAQ:240550
|
PP&E Gross
₩67.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
PP&E Gross
₩476.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
SD Biosensor Inc
KRX:137310
|
PP&E Gross
₩485.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
PP&E Gross
₩150.2B
|
CAGR 3-Years
90%
|
CAGR 5-Years
85%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
PP&E Gross
₩83.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
33%
|
CAGR 10-Years
22%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
PP&E Gross
₩74.9B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
DongBang Medical Co Ltd
Glance View
Dongbang Medical Co., Ltd. engages in the manufacturing and sale of oriental and aesthetic medical devices. The company is headquartered in Boryeong, Chungcheongnam-Do. The company went IPO on 2025-02-13. The firm operates its business through two segments. The Cosmetic Medical Devices segment is mainly engaged in the manufacture and sales of hyaluronic acid dermal filler, cannulas, thread and needles. The Oriental Medical Devices segment is mainly engaged in the production of sterrile acupuncture needles for single use and air extraction cupping device. In addition, the Company also provides mask pads, face cream and serum, clean wash, shampoo and treatment.
See Also
What is DongBang Medical Co Ltd's PP&E Gross?
PP&E Gross
67.3B
KRW
Based on the financial report for Dec 31, 2025, DongBang Medical Co Ltd's PP&E Gross amounts to 67.3B KRW.
What is DongBang Medical Co Ltd's PP&E Gross growth rate?
PP&E Gross CAGR 3Y
18%
Over the last year, the PP&E Gross growth was 17%. The average annual PP&E Gross growth rates for DongBang Medical Co Ltd have been 18% over the past three years .
